Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1557
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 6 3706-3714
Copyright © 2005 by The Endocrine Society
Medroxyprogesterone Acetate and Dihydrotestosterone Induce Coronary Hyperreactivity in Intact Male Rhesus Monkeys
Rajesh G. Mishra,
R. Kent Hermsmeyer,
Koichi Miyagawa,
Philip Sarrel,
Barry Uchida,
Frank Z. Stanczyk,
Kenneth A. Burry,
D. Roger Illingworth and
Frank J. Nordt
Dimera, Inc. (R.G.M., R.K.H.), Portland, Oregon 97210; Oregon Health and Science University (B.U., K.A.B., D.R.I.), Portland, Oregon 97239; Nagoya City Kohsein Hospital (K.M.), Nagoya, Japan; Yale University Medical School (P.S.), New Haven, Connecticut 06510; University of Southern California (F.Z.S.), Los Angeles, California 90033; and Rhein Consulting Laboratories (F.J.N.), Portland, Oregon 97225
Address all correspondence and requests for reprints to: Dr. R. Kent Hermsmeyer, Dimera, Inc., 2525 NW Lovejoy, Suite 311, Portland, Oregon 97210. E-mail: rkh{at}dimera.net.
Coronary hyperreactivity (CH), characterized by persistent severe vasoconstrictions in response to vasoconstrictor challenge, is oppositely influenced by progesterone (P) and medroxyprogesterone acetate (MPA) treatment in surgically menopausal primates. In this study we tested whether multiweek MPA or dihydrotestosterone (DHT) exposure induced CH in intact male rhesus monkeys. Coronary angiographic experiments with intracoronary serotonin and the thromboxane A2 analog U46619 stimulated brief vasoconstriction (for 13 min) in large epicardial coronaries in untreated male monkeys. In contrast, MPA- and DHT-treated monkeys displayed long-duration constrictions (>5 min), with significantly greater reductions in the minimal diameters of epicardial coronaries. Immunocytochemistry demonstrated androgen receptors (AR) and P receptors in aorta and coronary arteries, and immunocytochemistry and Western blotting showed AR and P receptors in rhesus coronary vascular muscle cells. In vivo, MPA or DHT increased thromboxane prostanoid (TP) receptor expression in the aorta. In vitro, MPA or DHT increased, whereas P did not change, TP receptor expression in primary coronary vascular muscle cell. This MPA- or DHT-mediated increase in TP receptor expression was attenuated by the AR antagonist flutamide. MPA or DHT induction of CH in intact adult male primates, hypothesized to occur via androgenic up-regulation of vascular muscle TP receptor expression, could predispose to CH-mediated myocardial ischemia.
This article has been cited by other articles:

|
 |

|
 |
 
K. L. Matthiesson and R. I. McLachlan
Male hormonal contraception: concept proven, product in sight?
Hum. Reprod. Update,
July 1, 2006;
12(4):
463 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Mishra, F. Z. Stanczyk, K. A. Burry, S. Oparil, B. S. Katzenellenbogen, M. L. Nealen, J. A. Katzenellenbogen, and R. K. Hermsmeyer
Metabolite ligands of estrogen receptor-{beta} reduce primate coronary hyperreactivity
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H295 - H303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag
Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6603 - 6608.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by The Endocrine Society